Literature DB >> 22313804

Clinical significance of reactive post-capillary pulmonary hypertension in patients with left heart disease.

Shunsuke Tatebe1, Yoshihiro Fukumoto, Koichiro Sugimura, Saori Miyamichi-Yamamoto, Tatsuo Aoki, Yutaka Miura, Kotaro Nochioka, Kimio Satoh, Hiroaki Shimokawa.   

Abstract

BACKGROUND: Post-capillary pulmonary hypertension (pc-PH) is a disorder with elevated pulmonary arterial pressure and pulmonary vascular resistance (PVR) because of left heart disease (LHD), and is classified as reactive (PVR >2.5 WU) or passive (PVR ≤ 2.5 WU). However, the clinical significance of these pc-PH subtypes remains to be elucidated. METHODS AND
RESULTS: We examined 676 consecutive patients with chronic heart failure (CHF) (NYHA ≥ 2), and found that 158 (23%) had pc-PH: reactive pc-PH in 58 and passive pc-PH in 100. Univariate analysis showed that 4 factors were significantly associated with reactive pc-PH and multivariate analysis showed that female sex was the only independent predictor of reactive pc-PH (odds ratio 2.12, 95% confidence interval (CI) 1.05-4.30, P=0.03). During the mean follow-up period of 2.6 years, 125 CHF patients (18%) died, including 22 with reactive pc-PH and 24 with passive pc-PH (P<0.001). Multivariate Cox regression analysis showed that elevated PVR was independently associated with higher mortality (hazard ratio 1.18, 95%CI 1.03-1.35, P=0.02). Kaplan-Meier analysis demonstrated that the prognosis of patients with reactive pc-PH was significantly worse than for those with no PH or passive pc-PH. Reactive pc-PH was a significant prognostic factor regardless of CHF etiology (ischemic vs. non-ischemic) or reduced/preserved LV ejection fraction (HFrEF vs. HFpEF).
CONCLUSIONS: Reactive pc-PH is characterized by predominant female sex and is a significant prognostic factor of LHD with PH.

Entities:  

Mesh:

Year:  2012        PMID: 22313804     DOI: 10.1253/circj.cj-11-1288

Source DB:  PubMed          Journal:  Circ J        ISSN: 1346-9843            Impact factor:   2.993


  14 in total

Review 1.  Treatment and Prognosis of Pulmonary Hypertension in the Left Ventricular Assist Device Patient.

Authors:  Christopher W Jensen; Andrew B Goldstone; Y Joseph Woo
Journal:  Curr Heart Fail Rep       Date:  2016-06

Review 2.  Epidemiology of pulmonary hypertension and right ventricular failure in left heart failure.

Authors:  Thenappan Thenappan; Mardi Gomberg-Maitland
Journal:  Curr Heart Fail Rep       Date:  2014-12

3.  Combined Post- and Precapillary Pulmonary Hypertension in Patients With Heart Failure.

Authors:  Michael E Rezaee; Elizabeth L Nichols; Mandeep Sidhu; Jeremiah R Brown
Journal:  Clin Cardiol       Date:  2016-10-21       Impact factor: 2.882

4.  The impact of preoperative and postoperative pulmonary hypertension on long-term surgical outcome after mitral valve repair for degenerative mitral regurgitation.

Authors:  Takashi Murashita; Yukikatsu Okada; Hideo Kanemitsu; Naoto Fukunaga; Yasunobu Konishi; Ken Nakamura; Tadaaki Koyama
Journal:  Ann Thorac Cardiovasc Surg       Date:  2014-04-18       Impact factor: 1.520

Review 5.  Left ventricular dysfunction with pulmonary hypertension: part 2: prognosis, noninvasive evaluation, treatment, and future research.

Authors:  Andreas P Kalogeropoulos; Vasiliki V Georgiopoulou; Barry A Borlaug; Mihai Gheorghiade; Javed Butler
Journal:  Circ Heart Fail       Date:  2013-05       Impact factor: 8.790

6.  Liver dysfunction assessed by model for end-stage liver disease excluding INR (MELD-XI) scoring system predicts adverse prognosis in heart failure.

Authors:  Satoshi Abe; Akiomi Yoshihisa; Mai Takiguchi; Takeshi Shimizu; Yuichi Nakamura; Hiroyuki Yamauchi; Shoji Iwaya; Takashi Owada; Makiko Miyata; Takamasa Sato; Satoshi Suzuki; Masayoshi Oikawa; Atsushi Kobayashi; Takayoshi Yamaki; Koichi Sugimoto; Hiroyuki Kunii; Kazuhiko Nakazato; Hitoshi Suzuki; Shu-ichi Saitoh; Yasuchika Takeishi
Journal:  PLoS One       Date:  2014-06-23       Impact factor: 3.240

7.  Pulmonary Arterial Capacitance Predicts Cardiac Events in Pulmonary Hypertension Due to Left Heart Disease.

Authors:  Koichi Sugimoto; Akiomi Yoshihisa; Kazuhiko Nakazato; Yuichiro Jin; Satoshi Suzuki; Tetsuro Yokokawa; Tomofumi Misaka; Takayoshi Yamaki; Hiroyuki Kunii; Hitoshi Suzuki; Shu-Ichi Saitoh; Yasuchika Takeishi
Journal:  PLoS One       Date:  2016-11-22       Impact factor: 3.240

8.  Echocardiographic assessment of pulmonary artery systolic pressure and outcomes in ambulatory heart failure patients.

Authors:  Andreas P Kalogeropoulos; Sarawut Siwamogsatham; Salim Hayek; Song Li; Anjan Deka; Catherine N Marti; Vasiliki V Georgiopoulou; Javed Butler
Journal:  J Am Heart Assoc       Date:  2014-02-03       Impact factor: 5.501

Review 9.  Predictors of hospitalisations for heart failure and mortality in patients with pulmonary hypertension associated with left heart disease: a systematic review.

Authors:  Anastase Dzudie; Andre Pascal Kengne; Friedrich Thienemann; Karen Sliwa
Journal:  BMJ Open       Date:  2014-07-10       Impact factor: 2.692

10.  Electrocardiogram signs of right ventricular hypertrophy may help identify pulmonary hypertension in patients with dilated cardiomyopathy.

Authors:  Chengzhi Chen; Jingyan Liu; Zhiyong Liu; Xin He; Xuming Yuan; Xiufen Ouyang; Lei Wang; Xiaoping Li
Journal:  Int J Cardiol Heart Vasc       Date:  2018-12-27
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.